LifeArc and PharmEnable team up to discover novel oral antiviral drugs to treat coronaviruses

Aiming to produce an oral therapeutic with broad applicability across coronaviruses.

Novartis BIOME UK announces selection for the HealthHub 21 Challenge, in collaboration with KQ Labs and LifeArc

Novartis UK announces companies selected for the Novartis BIOME UK HealthHub 21 Challenge

LifeArc publishes expert advice to support work around repurposing medicines

Guide will support researchers and charities who focus on diseases which have few effective therapies

PostEra and LifeArc collaborate on novel open science initiative to develop new antiviral for COVID-19

£100,000 grant to develop a globally-accessible, oral antiviral as part of the COVID Moonshot initiative

KQ Labs opens applications for health start-ups for its annual accelerator programme

This year's programme delivered by the Francis Crick Institute and funded by LifeArc

Advise & Connect: LifeArc offers expertise and funding to help tackle COVID-19

Access our advice, network and potentially more

LifeArc and the MND Association commit £1m to boost search for new treatments

Bolstered by the fundraising efforts of Leeds Rhinos’ coach, Kevin Sinfield

LifeArc invests in Cumulus Neuroscience

Investment part of £6 million funding round led by Dementia Discovery Fund, supported by UK Future Fund